undefined
EUTM file information

018905745

ACHILLES

July 24, 2023

Trademark Summary

The trademark application ACHILLES was filed by Achilles Therapeutics UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 14, 2023, and it was registered by office on December 22, 2023 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Medical and veterinary preparations for therapeutic purposes
    2. Preparations for cancer therapy
    3. Antibodies
    4. Vaccines
    5. Personalised cancer vaccines
    6. Neoantigen vaccines
    7. Preparations for cell therapy
    8. Neoantigen-specific T cells
    9. TCR-engineered T cells
    10. Preparations for modifying human or animal cells for medical or therapeutic purposes
    11. Preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes.
  • The mark was filed in class 40 with Custom manufacture of therapeutic drugs, namely custom manufacture of cell therapies, cancer therapies, neoantigen-specific T cells, TCR-engineered T cells, cancer vaccines and neoantigen vaccines.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services and research and design relating thereto
    2. Industrial analysis and research services
    3. Medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes
    4. Scientific research in the development of new cancer therapies, including neoantigen-specific T cells and TCR-engineered T cells
    5. Scientific research in human and animal cell therapy
    6. Scientific research into vaccines, including personalised cancer vaccines and neoantigen vaccines
    7. Scientific research into preparations for manipulating and adapting human and animal cells
    8. Consultancy relating to all the aforesaid services.
  • The mark was filed in class 44 with following description of goods:
    1. Medical services
    2. Veterinary services
    3. Services in the extraction of human and animal cells from patients
    4. Manipulation of human and animal cells for therapeutic purposes
    5. Reinsertion of cells into human and animal patients
    6. Providing advice and consultancy in the field of medical and veterinary therapies
    7. Providing advice and consultancy in the field of cancer therapies and cancer vaccines.